K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratificationAndrew S. Levey, Antonio M. Gotto, Josef Coresh et al.|Data Archiving and Networked Services (DANS)|2002Cited by 11.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney diseaseShaul G. Massry, John M. Newmann, Karyn A. Tappe et al.|Data Archiving and Networked Services (DANS)|2003Cited by 2.5k
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary EventsPaul M. Ridker, Antonio M. Gotto|New England Journal of Medicine|2001Cited by 1.6k
Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease CasesShih-Jen Hwang, Eric Boerwinkle, Christie M. Ballantyne et al.|Circulation|1997Cited by 1.3k
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With StatinsS. Matthijs Boekholdt, John J.P. Kastelein, Benoît J. Arsenault et al.|JAMA|2012Cited by 800